Acinetobacter baumannii infection in the neonatal intensive care unit

Iranian Journal of Public Health

Volumn 37, Issue 3, 2008, Pages 107-112

  Al Jarousha, A M K ^a   El Qouga, I A ^b   El Jadba, A H N ^c   Al Afifi, A S ^d  

^a AL AZHAR UNIVERSITY   (Palestine)

^b Military Medical Services   (Palestine)

^c Al Dorra Pediatric Hospital   (Palestine)

^d Al Nasser Pediatric Hospital   (Palestine)

Author keywords

Acinetobacter baumannii; Multidrug resistance; Neonatal intensive care unit; Nosocomial infection

Indexed keywords

EID: 56549103909     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Goldmann DA, Freeman J, Durbin WA (1983). Nosocomial infection and death in a neonatal intensive-care unit. J Infect Dis, 147(4): 635-41.
2. Costantini M, Donisi PM, Turrin MG, Diana L (1987). Hospital acquired infections surveillance and control in intensive care services. Results of an incidence study. Eur J Epidemiol, 3(4): 347-55.
3. Brodie SB, Sands KE, Gray JE, Parker RA, Goldmann DA, Davis RB, et al. (2000). Occurrence of nosocomial bloodstream infections in six neonatal intensive care units. Pediatr infect Dis J, 19(1): 56-62.
4. Mathur P, Kapil A, Das B (2005). Nosocomial bacteremia in intensive care unit patients of a tertiary care center. Indian J Med Res, 122: 305-8.
5. Minino A, Smith BL (2001). Death: preliminary data for 2000. Natl Vital Stat Rep, 49(12):1-40.
6. Baine WB, Yu W, Summe JP (2001). The epidemiology of hospitalization of elderly Americans for septicemia or bacteremia in 1991-1998: application of Medicare claims data. Ann Epidemiol, 11(2): 118-26.
7. McBean M, Rajamani S (2001). Increasing rates of hospitalization due to septicemia in the US elderly population, 1986-1977. J Infect Dis, 183(4): 596-603.
8. Pittet D, Tarara D, Wenzel RP (1994). Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA, 271(20): 1598-601.
9. Rello J (1999). Impact of nosocomial infections on outcome myths and evidence. Infect Control Hosp Epidemiol, 20(6): 392-94.
10. Abramson MA, Sexton DJ (1999). Nosocomial Methicillin-resistant and Methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect. Control Hosp Epdemiol, 20(6): 408-11.
11. DiGiovine B, Chenwoeth C, Watts C, Higgins M (1999). The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med, 160(3): 976-81.
12. Orsi GB, Di Stefano L, Noah N (2002). Hospital-acquired, laboratory-confirmed bloodstream infection: Increased hospitals stay and direct costs. Infect Control Hosp Epidemiol, 2002; 23(4): 190-97.
13. Lahiri KK, Mani NS, Purai SS (2004). Acinetobacter spp as nosocomial pathogen: clinical significance and antimicrobial sensitivity. MJAFI, 60: 7-10.
14. Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J (2000). Endemic carbapenem- resistant Acinetobacter species in brooklyn, New York: citywide prevalence, interinstitutional spread and relation to antibiotic usage. Clin Infect Dis, 31(1): 101-6.
15. Acar JF (1997). Consequences of bacterial resistance to antibiotics in medical practice. Clin Infect Dis, 24(suppl): S17-18.
16. Landman D, Quale JM, Mayorga D, Adedeji A, et al. (2002). Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med, 8; 162(13):1515-20.
17. Bergogne-Berezin E, Towner KJ (1996). Acinetobacter spp as Nosocomial pathogens: microbiological. Clinical and epidemiological features. Clin Microbiol Rev, 9(2):148-65.
18. Wendi C, Dietz E, mRuden H (1997). Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol, 35(6): 1394-97.
19. Villegas MV, hartstein AI (2003). Acinetobacter outbreaks 1977-2000. Infect Control hosp epidemiol, 24(4): 284-95.
20. Murray BE, Moellering RC (1979). Aminoglycoside- modifying enzymes among clinical isolates of Acinetobacter calcoaceticus subsp. Anitratus: explanation for highlevel Aminoglycoside resistance. Antimicrobial Agents Chemother, 15(2):190-99.
21. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. (2002). Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep, 9; 51(RR-10): 1-29.
22. Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DF (2003). Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother, 47(5): 1681-88.
23. Greenberg D, Shinwell ES, Yagupsky P, Greenberg S, Leibovitz E, Mazor M, et al. (1997). A prospective study of neonatal sepsis and meningitis in Southern Israel. Pediatr Infect Dis J, 16(8): 768-73.
24. Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RL, Bauer CR, et al. (1998). Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. Ped Infect Dis J, 17(7): 593-8.
25. McDonald LC, Walker M, Carson L, Arduino M, Aguero SM, Gomez P, et al. (1998). Outbreak of Acinetobacter spp. blood-stream infections in a nursery associated with contaminated aerosols and air conditioners. Pediatr Infect Dis J, 17(8):716-22.
26. Melamed R, Greenberg D, Porat N, Karplus M, Zmora E, Golan A, et al. (2003). Successful control of an Acinetobacter baumannii outbreak in a neonatal intensive care unit. J Hosp Infect, 53(1): 31-8.
27. Cordero L, Sananes M, Ayers LW (1999). Bloodstream infections in a neonatal intensive- care unit: 12 years' experience with an antibiotic control program. Infect. Control Hosp Epidemiol, 20(4): 242-46.
28. Royle J, Halasz S, Eagles G, Gilbert G, Dalton D, Jelfs P, et al. (1999). Outbreak of extended spectrum b-lactamase producing Klebsiella pneumoniae in a neonatal unit. Arch Dis Child Fetal Neonatal, 80(1): F64-8.